| Current Price | $101.84 | Mkt Cap | $9.6B |
|---|---|---|---|
| Open | $103.04 | P/E Ratio | 26.22 |
| Prev. Close | $101.84 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $101.52 - $103.58 | Volume | 38 |
| 52-Wk Range | $84.77 - $120.27 | Avg. Daily Vol. | 539,189 |
Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis.
| Current Price | $101.84 | Mkt Cap | $9.6B |
|---|---|---|---|
| Open | $103.04 | P/E Ratio | 26.22 |
| Prev. Close | $101.84 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $101.52 - $103.58 | Volume | 38 |
| 52-Wk Range | $84.77 - $120.27 | Avg. Daily Vol. | 539,189 |
The best Bull and Bear pitches based on recency and number of recommendations.
NBIX is ow non sale just as the company is ready to begin marketing Ongentys as COVID-19 restrictions ease. There could be significant demand for thIS drug because roughly 70% of the 1 million Americans with Parkinson's disease currently take… More
Neurocrine has been turning in solid pipeline progress for several years now but they haven't had much success holding gains in the share price. Now that the phase III trial of elagolix is in progress I expect at least a year before all 875 patients… More
Read the most recent pitches from players about NBIX.
Recs
Rainman19
(36.89)
Submitted: 10/13/2021 5:40:24 PM :
Start Price:
$101.94
NASDAQ:NBIX Score:
-3.95
This cheap biotech stock doesn‘t get enough attention and that is a big chance!
Recs
jjhegi
(65.81)
Submitted: 12/12/2020 9:23:03 PM :
Start Price:
$117.21
NASDAQ:NBIX Score:
-43.00
Skyrocketing revenues, no long-term debt, loads of cash. strong free cash flow, CEO owns lots of stock.
Recs
Itsnottoolate
(85.00)
Submitted: 10/3/2020 8:36:33 PM :
Start Price:
$95.13
NASDAQ:NBIX Score:
-28.64
NBIX is ow non sale just as the company is ready to begin marketing Ongentys as COVID-19 restrictions ease.
There could be significant demand for thIS drug because roughly 70% of the 1 million Americans with Parkinson's disease currently take levodopa which to my understanding this is going to disrupt.
Find the members with the highest scoring picks in NBIX.
gsm1999 (44.42) Score: +4,028.73
The Score Leader is the player with the highest score across all their picks in NBIX.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| gsm1999 | 44.42 | 3/8/2010 |
|
5Y | $2.30 | +4,327.83% | +299.10% | +4,028.73 | 0 Comment | |
| awsumrocker | 85.50 | 3/10/2010 |
|
3M | $2.35 | +4,233.62% | +298.23% | +3,935.39 | 0 Comment | |
| stockamuteur | 66.86 | 4/8/2010 |
|
5Y | $2.57 | +3,862.65% | +286.61% | +3,576.03 | 0 Comment | |
| Tadpole85 | 61.08 | 1/5/2010 |
|
1Y | $2.68 | +3,700.00% | +302.62% | +3,397.38 | 0 Comment | |
| borcobob | 76.37 | 12/28/2009 |
|
3Y | $2.82 | +3,511.35% | +303.91% | +3,207.44 | 0 Comment | |
| MicroOptions | 58.68 | 4/15/2010 |
|
5Y | $3.10 | +3,185.16% | +276.90% | +2,908.26 | 0 Comment | |
| MicroMikey | 81.44 | 4/15/2010 |
|
5Y | $3.10 | +3,185.16% | +276.90% | +2,908.26 | 0 Comment | |
| royeknox | 73.43 | 8/10/2009 |
|
5Y | $3.03 | +3,261.06% | +354.96% | +2,906.10 | 0 Comment | |
|
foolshand | < 20 | 7/27/2009 |
|
3W | $3.25 | +3,033.54% | +368.08% | +2,665.46 | 0 Comment |
| carcanario | < 20 | 4/23/2010 |
|
3M | $3.36 | +2,935.47% | +275.19% | +2,660.28 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
